India Successfully Test-Launches Agni-1 Ballistic Missile At Chandipur Test Range In Odisha
India successfully test-fired the nuclear-capable Agni-1 missile from Chandipur on Friday. Conducted under the Strategic Forces Command, the trial validated all operational and technical parameters. Developed by the Defence Research and Development Organisation, the missile can strike targets between 700 and 1,200 kilometres away.
India on Friday successfully conducted a test launch of the nuclear-capable Agni-1 ballistic missile from the Integrated Test Range at Chandipur, official sources said.
The launch was carried out under the supervision of the Strategic Forces Command, which functions under India’s Nuclear Command Authority and is responsible for managing the country’s strategic nuclear assets.
According to Defence Ministry release, the trial successfully met all operational and technical objectives, reaffirming the missile’s reliability and combat readiness. The test formed part of India’s routine evaluation exercises aimed at ensuring the effectiveness and preparedness of strategic defence systems already inducted into service.
Developed by the Defence Research and Development Organisation, the Agni-1 missile is capable of striking targets at a distance ranging from 700 km to 1,200 km. The missile is designed for short-range strategic operations and forms an important component of India’s nuclear deterrence capability.
A similar test of the Agni-1 missile had been conducted in July last year, during which all mission parameters were also successfully achieved.
RECENT STORIES
-
IPL Legend Chris Gayle Spotted Watching SRH Vs RCB Clash In Hyderabad; Pictures Go Viral -
India Successfully Test-Launches Agni-1 Ballistic Missile At Chandipur Test Range In Odisha -
Hinduja Foundation Offers MSc And PhD Scholarships For Indian Students At King's College London For... -
Mumbai Police Jeep Allegedly Reverses Nearly 1 Km On Coastal Road Ramp Near Worli Sea Face; Viral... -
Mumbai: BMC Plans 130-Bed Cancer Hospital In Bandra Amid Rising Cases
